Clinical Trial Update: Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a multi-drug adjuvant regimen for HER2-positive breast cancer, combining bevacizumab and trastuzumab with weekly paclitaxel fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Hospital Universitario Madrid Sanchinarro | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN